The global anticoagulation therapy market size was valued at USD 32.48 billion in 2024 and is expected to reach USD 61.88 billion by 2032, at a CAGR of 8.39% during the forecast period
The market growth is largely fueled by the rising prevalence of cardiovascular diseases, an expanding aging population, and significant technological advancements in drug development, particularly in novel oral anticoagulants (NOACs).
Furthermore, increasing awareness of cardiovascular health and the growing demand for more effective and safer treatment options are establishing anticoagulants as a crucial therapy. These converging factors are accelerating the uptake of anticoagulation solutions, thereby significantly boosting the industry's growth
2 weergaven